• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻度 COPD 是否会影响老年人的预后?

Does mild COPD affect prognosis in the elderly?

机构信息

Centro per la Salute dell'Anziano, Area di Geriatria, Università Campus Biomedico, Roma, Italy.

出版信息

BMC Pulm Med. 2010 Jun 7;10:35. doi: 10.1186/1471-2466-10-35.

DOI:10.1186/1471-2466-10-35
PMID:20529281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2903556/
Abstract

BACKGROUND

Chronic obstructive pulmonary disease (COPD) affects independence and survival in the general population, but it is unknown to which extent this conclusion applies to elderly people with mild disease. The aim of this study was to verify whether mild COPD, defined according to different classification systems (ATS/ERS, BTS, GOLD) impacts independence and survival in elderly (aged 65 to 74 years) or very elderly (aged 75 years or older) patients.

METHODS

We used data coming from the Respiratory Health in the Elderly (Salute Respiratoria nell'Anziano, SaRA) study and compared the differences between the classification systems with regards to personal capabilities and 5-years survival, focusing on the mild stage of COPD.

RESULTS

We analyzed data from 1,159 patients (49% women) with a mean age of 73.2 years (SD: 6.1). One third of participants were 75 years or older. Mild COPD, whichever was its definition, was not associated with worse personal capabilities or increased mortality after adjustment for potential confounders in both age groups.

CONCLUSIONS

Mild COPD may not affect survival or personal independence of patients over 65 years of age if the reference group consists of patients with a comparable burden of non respiratory diseases. Comorbidity and age itself likely are main determinants of both outcomes.

摘要

背景

慢性阻塞性肺疾病(COPD)会影响普通人群的独立性和生存能力,但尚不清楚这一结论在轻度疾病的老年人群中适用到何种程度。本研究旨在验证根据不同分类系统(ATS/ERS、BTS、GOLD)定义的轻度 COPD 是否会影响老年(65 至 74 岁)或非常老年(75 岁或以上)患者的独立性和生存能力。

方法

我们使用来自老年呼吸健康研究(Salute Respiratoria nell'Anziano,SaRA)的数据,并比较了不同分类系统在个人能力和 5 年生存率方面的差异,重点关注 COPD 的轻度阶段。

结果

我们分析了来自 1159 名患者(49%为女性)的数据,这些患者的平均年龄为 73.2 岁(SD:6.1)。三分之一的参与者年龄在 75 岁或以上。无论采用哪种定义,轻度 COPD 与个人能力下降或调整潜在混杂因素后两组患者死亡率增加均无关。

结论

如果参考组由非呼吸系统疾病负担相当的患者组成,那么 65 岁以上患者的轻度 COPD 可能不会影响其生存或个人独立性。合并症和年龄本身可能是这两个结果的主要决定因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f01a/2903556/517faa09695b/1471-2466-10-35-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f01a/2903556/01c4f833f8dd/1471-2466-10-35-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f01a/2903556/517faa09695b/1471-2466-10-35-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f01a/2903556/01c4f833f8dd/1471-2466-10-35-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f01a/2903556/517faa09695b/1471-2466-10-35-2.jpg

相似文献

1
Does mild COPD affect prognosis in the elderly?轻度 COPD 是否会影响老年人的预后?
BMC Pulm Med. 2010 Jun 7;10:35. doi: 10.1186/1471-2466-10-35.
2
Discriminative and predictive properties of disease-specific and generic health status indexes in elderly COPD patients.老年慢性阻塞性肺疾病患者中疾病特异性和一般健康状况指标的鉴别及预测特性
BMC Pulm Med. 2008 Aug 13;8:14. doi: 10.1186/1471-2466-8-14.
3
Alternative ways of expressing FEV1 and mortality in elderly people with and without COPD.在有和没有 COPD 的老年人中,表达 FEV1 和死亡率的替代方法。
Eur Respir J. 2013 Apr;41(4):800-5. doi: 10.1183/09031936.00008812. Epub 2012 Jul 12.
4
Correlates of mortality in elderly COPD patients: focus on health-related quality of life.老年慢性阻塞性肺疾病患者死亡率的相关因素:关注健康相关生活质量
Respirology. 2009 Jan;14(1):98-104. doi: 10.1111/j.1440-1843.2008.01441.x.
5
Severity of acidosis affects long-term survival in COPD patients with hypoxemia after intensive care unit discharge.酸中毒的严重程度影响慢性阻塞性肺疾病(COPD)合并低氧血症患者在重症监护病房出院后的长期生存。
Int J Chron Obstruct Pulmon Dis. 2018 May 9;13:1495-1506. doi: 10.2147/COPD.S159504. eCollection 2018.
6
Relationship between chronic obstructive pulmonary disease and subclinical coronary artery disease in long-term smokers.长期吸烟与慢性阻塞性肺疾病和亚临床冠状动脉疾病的关系。
Eur Heart J Cardiovasc Imaging. 2013 Dec;14(12):1159-66. doi: 10.1093/ehjci/jet057. Epub 2013 May 2.
7
Is there any correlation between the ATS, BTS, ERS and GOLD COPD's severity scales and the frequency of hospital admissions?美国胸科学会(ATS)、英国胸科学会(BTS)、欧洲呼吸学会(ERS)和慢性阻塞性肺疾病全球倡议(GOLD)的慢性阻塞性肺疾病严重程度分级与住院频率之间是否存在相关性?
Respir Med. 2004 Feb;98(2):178-83. doi: 10.1016/j.rmed.2003.09.011.
8
[Impact of Chronic Obstructive Pulmonary Disease on Risk of Recurrence in Patients with Resected Non-small Cell Lung Cancer].[慢性阻塞性肺疾病对非小细胞肺癌切除术后患者复发风险的影响]
Zhongguo Fei Ai Za Zhi. 2018 Mar 20;21(3):215-220. doi: 10.3779/j.issn.1009-3419.2018.03.21.
9
Evaluation of health outcomes in elderly patients with asthma and COPD using disease-specific and generic instruments: the Salute Respiratoria nell'Anziano (Sa.R.A.) Study.使用疾病特异性和通用工具评估老年哮喘和慢性阻塞性肺疾病患者的健康结局:Salute Respiratoria nell'Anziano(Sa.R.A.)研究
Chest. 2001 Sep;120(3):734-42. doi: 10.1378/chest.120.3.734.
10
Aging and disability affect misdiagnosis of COPD in elderly asthmatics: the SARA study.
Chest. 2003 Apr;123(4):1066-72. doi: 10.1378/chest.123.4.1066.

引用本文的文献

1
Risk factors for cardiovascular disease in patients with COPD: mild-to-moderate COPD versus severe-to-very severe COPD.COPD 患者心血管疾病的风险因素:轻度至中度 COPD 与重度至极重度 COPD。
J Bras Pneumol. 2016 May-Jun;42(3):179-84. doi: 10.1590/S1806-37562015000000121.
2
A combined pulmonary function and emphysema score prognostic index for staging in Chronic Obstructive Pulmonary Disease.一种用于慢性阻塞性肺疾病分期的肺功能与肺气肿评分联合预后指数。
PLoS One. 2014 Oct 24;9(10):e111109. doi: 10.1371/journal.pone.0111109. eCollection 2014.
3
Using cluster analysis to identify phenotypes and validation of mortality in men with COPD.

本文引用的文献

1
The Prevalence of chronic obstructive pulmonary disease among Danes aged 45-84 years: population-based study.45至84岁丹麦人群中慢性阻塞性肺疾病的患病率:基于人群的研究。
COPD. 2008 Dec;5(6):347-52. doi: 10.1080/15412550802522635.
2
A 4-year trial of tiotropium in chronic obstructive pulmonary disease.噻托溴铵用于慢性阻塞性肺疾病的4年试验。
N Engl J Med. 2008 Oct 9;359(15):1543-54. doi: 10.1056/NEJMoa0805800. Epub 2008 Oct 5.
3
Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction.
使用聚类分析鉴定 COPD 男性患者的表型和验证死亡率。
Lung. 2014 Dec;192(6):889-96. doi: 10.1007/s00408-014-9646-x. Epub 2014 Oct 7.
4
Epidemiology and management of common pulmonary diseases in older persons.老年人常见肺部疾病的流行病学和管理。
J Gerontol A Biol Sci Med Sci. 2012 Mar;67(3):276-91. doi: 10.1093/gerona/glr251. Epub 2012 Feb 15.
5
Up-to-date on mortality in COPD - report from the OLIN COPD study.慢性阻塞性肺疾病死亡率最新报告——OLIN COPD 研究。
BMC Pulm Med. 2012 Jan 9;12:1. doi: 10.1186/1471-2466-12-1.
采用FEV1/FVC比值的正常下限可减少气道阻塞的误诊。
Thorax. 2008 Dec;63(12):1046-51. doi: 10.1136/thx.2008.098483. Epub 2008 Sep 11.
4
FEV1/FVC and FEV1 for the assessment of chronic airflow obstruction in prevalence studies: do prediction equations need revision?在患病率研究中用于评估慢性气流阻塞的FEV1/FVC和FEV1:预测方程需要修订吗?
Respir Med. 2008 Nov;102(11):1568-74. doi: 10.1016/j.rmed.2008.06.007. Epub 2008 Jul 26.
5
Predictors of Survival in COPD: more than just the FEV1.慢性阻塞性肺疾病(COPD)生存的预测因素:不仅仅是第一秒用力呼气容积(FEV1)
Respir Med. 2008 Jun;102 Suppl 1:S27-35. doi: 10.1016/S0954-6111(08)70005-2.
6
Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD.改良版GOLD 1期慢性阻塞性肺疾病患者的肺功能、医疗服务利用情况及生活质量的长期下降
Thorax. 2008 Sep;63(9):768-74. doi: 10.1136/thx.2007.093724. Epub 2008 May 27.
7
Reference equations for lung function screening of healthy never-smoking adults aged 18-80 years.18至80岁健康非吸烟成年人肺功能筛查的参考方程。
Eur Respir J. 2008 Apr;31(4):860-8. doi: 10.1183/09031936.00091407. Epub 2007 Dec 5.
8
Differences in cardiopulmonary exercise test results by American Thoracic Society/European Respiratory Society-Global Initiative for Chronic Obstructive Lung Disease stage categories and gender.根据美国胸科学会/欧洲呼吸学会-慢性阻塞性肺疾病全球倡议的分期类别及性别划分的心肺运动试验结果差异
Chest. 2007 Oct;132(4):1204-11. doi: 10.1378/chest.07-0593.
9
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.沙美特罗与丙酸氟替卡松及慢性阻塞性肺疾病患者的生存率
N Engl J Med. 2007 Feb 22;356(8):775-89. doi: 10.1056/NEJMoa063070.
10
Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?老年人的肺功能测试——我们还能将FEV1/FVC<70%作为慢性阻塞性肺疾病(COPD)的标准吗?
Respir Med. 2007 Jun;101(6):1097-105. doi: 10.1016/j.rmed.2006.11.019. Epub 2007 Jan 18.